In a new interview, @deirdre_tobias, ScD, discusses the 2025–2030 Dietary Guidelines for Americans, including areas of confusion and contradiction. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/JDJVFWxeeI
𝗣𝘂𝗯𝗹𝗶𝗰 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝗹𝗲𝗿𝘁𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:
On April 27, 2026, a man (later classified as Patient 3 in the outbreak) was medically evacuated to Ascension Island from the Dutch-flagged expedition cruise ship 𝘔𝘝 𝘏𝘰𝘯𝘥𝘪𝘶𝘴; he had severe acute respiratory infection (SARI) and reported shortness of breath and fever that had begun on April 21. He had signs of pneumonia, although findings on chest radiography were unremarkable. While he was on Ascension Island, his condition worsened, and he was transferred to Johannesburg, South Africa, for ventilator support and intensive care. He was in shock and had acute respiratory distress syndrome; findings on chest radiography were consistent with atypical pneumonia. The differential diagnosis in this clinical context is very broad and includes atypical pneumonias, bacterial or fungal sepsis, and vectorborne diseases such as malaria or dengue. The diagnostic evaluation, including respiratory pathogen panels, malaria smear and antigen, fungal biomarkers, blood cultures, and legionella urinary antigen, was unrevealing.
On May 2, the cruise ship had a total of 147 persons on board, including 88 passengers and 59 crew members, from 23 countries. As of May 13, 2026, a total of 10 cases had been identified (an 11th was subsequently reclassified as not a case), including 3 resulting in death (seen in figure). However, because not everyone on board was tested, 3 deaths among 10 cases may represent an overestimation of the case fatality ratio. All cases to date have been among passengers or crew on board the ship. Beyond the first 3 cases, 7 additional confirmed or probable cases have been identified. A German national (Patient 4) died from a SARI on May 2, and later testing in the Netherlands confirmed Andes virus (ANDV). Two crew members — the doctor on the ship (Patient 5) and an expedition guide (Patient 6) — were medically evacuated to the Netherlands, tested positive by PCR and sequencing for ANDV on May 7 and 8, respectively, and were in stable condition at the time of this report.
Read “Andes Hantavirus Outbreak on a Cruise Ship, 2026,” which includes clinical details, case timeline, genetic sequencing of the virus, and unresolved transmission questions, by the Andes Virus Outbreak Working Group: https://t.co/dhb9RWFQ8i
Jatin M. Vyas, MD, PhD, discusses the effect of corporatization of academic medical centers on medical education and trainee development. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/kDxdOgFSMD
Amanda Banks, MD, discusses concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/Di0gRNCiWy
Sara Gerke, Dipl-Jur Univ, discusses a Utah pilot program involving an AI system that autonomously renews certain prescriptions. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/QiEm7iNM7m
Amy W. Stimpfel, PhD, RN, discusses a new policy that would cap loans for graduate nursing and other students. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/pWBzy2nc4e
Danielle D. Jones, PhD, MPH, discusses the development of tools to help family physicians address social determinants of health and advance health equity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/EaWjdLW1Cc
Lawrence P. Casalino, MD, PhD, discusses qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/tCnfhgItXA
Douglas J. Opel, MD, MPH, discusses the importance of clinician–parent communication amid changes to the childhood vaccine schedule. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/rFmTyPLZZv
In a new interview, @AbbasHassanMD, PhD, discusses the gap between the services that residents and fellows provide and the revenue that hospitals can capture. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/tLljcrssI0
Ruqaiijah Yearby, JD, MPH, discusses recent trends in health care markets and their implications for health equity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/APocCOukJn
Bruce A. Chabner, MD, discusses recent FDA statements regarding potential uses for leucovorin. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://nej.md/4aNrG4J
Sonja A. Rasmussen, MD, discusses the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/ZoOLQZ0zmF
Carmel Shachar, JD, MPH, discusses the opportunities and risks presented by the Rural Health Transformation Program. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/j4ahoOIaiM
In a new interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128), @LeemoreDafny, PhD, discusses the implications of corporatization of the U.S. health insurance industry. Full interview: https://t.co/l6DMyblzQJ
Robert Kocher, MD (@bobkocher), discusses strategies for improving blood-pressure control in the United States. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/XvHr3sN2fP
Tara Eicher, PhD, discusses changes in autism diagnosis in recent years and statements from the federal government regarding autism. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/fdQFjjANPO
Tara Sklar, JD, MPH (@trsklar), discusses U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/d8FCxsdch2
Rachel E. Sachs, JD, MPH, discusses recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/OH53U5l7ON
Ambar La Forgia, PhD (@ambarlaforgia), discusses the drivers and effects of corporatization of outpatient medical services. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): https://t.co/FWn72eLVqe